Clopidogrel 150 Mg/day to Overcome Low Responsiveness in Patients Undergoing Elective Percutaneous Coronary Intervention. Results from the Vasp-02 Randomized Study

被引：0

作者：

Aleil, Boris ^{[1
]}

Jacquemin, Laurent ^{[2
]}

De Poli, Fabien ^{[3
]}

Zaehringer, Michel ^{[1
]}

Collet, Jean-Philippe ^{[4
]}

Montalescot, Gilles ^{[4
]}

Cazenave, Jean-Pierre ^{[5
]}

Dickele, Marie-Claude ^{[3
]}

Monassier, Jean-Pierre ^{[2
]}

Gachet, Christian ^{[5
]}

机构：

[1] Clin Orangerie, Strasbourg, France

[2] Hop Emile Muller, Mulhouse, France

[3] Ctr Hosp Gen, Haguenau, France

[4] Hop La Pitie Salpetriere, Paris, France

[5] EFS Alsace, INSERM, U311, Strasbourg, France

来源：

CIRCULATION | 2008年 / 118卷 / 18期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S820 / S820

页数：1

共 50 条

[31] Use of prasugrel vs clopidogrel and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention in contemporary clinical practice: Results from the PROMETHEUS study
Haber, Usman
Sartori, Samantha
Aquino, Melissa
Kini, Annapoorna
Kapadia, Samir
Weiss, Sandra
Strauss, Craig
Muhlestein, J. Brent
Toma, Catalin
Rao, Sunil V.
DeFranco, Anthony
Poddar, Kanhaiya L.
Chandrasekhar, Jaya
Weintraub, William
Henry, Timothy D.
Bansilal, Sameer
Baker, Brian A.
Marrett, Elizabeth
Keller, Stuart
Effron, Mark
Pocock, Stuart
Mehran, Roxana
AMERICAN HEART JOURNAL, 2017, 188 : 73 - 81
[32] Prevalence of clOpidogrel 'resIstaNce' in a selected population of patients undergoing elective percutaneous coronary intervention at a tertiary cardiovascular centre in Trinidad: the POINT pilot study
Seecheran, Naveen Anand
Maharaj, Aarti
Boodhai, Brent
Seecheran, Rajeev
Seecheran, Valmiki
Persad, Sangeeta
Ramsaroop, Koomatie
Sandy, Sherry
Giddings, Stanley
Sakhamuri, Sateesh
Ali, Ronan
Motilal, Shastri
Teelucksingh, Surujpal
Tello-Montoliu, Antonio
OPEN HEART, 2019, 6 (01):
[33] Comparison of Adverse Cardiovascular Events and Bleeding Complications of Loading Dose of Clopidogrel 300 mg Versus 600 mg in Stable Patients Undergoing Elective Percutaneous Intervention (from the CADICE Study)
Fernandez, Andres
Aboodi, Michael S.
Milewski, Krzysztof
Delgado, Juan A.
Rodriguez, Arturo
Granada, Juan F.
AMERICAN JOURNAL OF CARDIOLOGY, 2011, 107 (01): : 6 - 9
[34] TICAGRELOR OR PRASUGREL VERSUS CLOPIDOGREL IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION FOR CHRONIC CORONARY SYNDROMES: RESULTS FROM A REAL-WORLD REGISTRY
Koshy, Anoop Ninan
Giustino, Gennaro
Sartori, Samantha
Hooda, Amit
Feng, Yihan
Snyder, Clayton
Smith, Kenneth
Kumar, Kartik
Chen, Shiwei
Krishnamoorthy, Parasuram Melarcode
Dhulipala, Vishal
Sweeny, Joseph M.
Khera, Sahil
Serrao, Gregory
Sharma, Raman
Dangas, George D.
Kini, Annapoorna Subhash
Mehran, Roxana
Sharma, Samin K.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 1298 - 1298
[35] A Randomized Trial of Prasugrel Versus Clopidogrel in Patients With High Platelet Reactivity on Clopidogrel After Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stents Results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel) Study
Trenk, Dietmar
Stone, Gregg W.
Gawaz, Meinrad
Kastrati, Adnan
Angiolillo, Dominick J.
Mueller, Ulrike
Richardt, Gert
Jakubowski, Joseph A.
Neumann, Franz-Josef
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (24) : 2159 - 2164
[36] Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention -an analysis from the prospective randomized PLATO trial
Steg, P. G.
Harrington, R. A.
Storey, R.
Emanuelsson, H.
Katus, H.
Mahaffey, K.
Meir, B.
Wojdyla, D.
Wallentin, L.
James, S.
EUROPEAN HEART JOURNAL, 2011, 32 : 415 - 416
[37] Impact of Early Abciximab Administration on Myocardial Reperfusion in Patients with ST-segment Elevation Myocardial Infarction Pretreated with 600 mg of Clopidogrel before Percutaneous Coronary Intervention. Multicenter Randomized Study
Dudek, Dariusz
Rakowski, Tomasz
Bartus, Stanislaw
Giszterowicz, Dawid
Zmudka, Krzysztof
Zalewski, Jaroslaw
Ochala, Andrzej
Wieja, Pawel
Janus, Bogdan
Dziewierz, Artur
Legutko, Jacek
Dubiel, Jacek S.
AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (8A): : 64I - 64I
[38] Abciximab for patients undergoing a percutaneous coronary intervention after pretreatment with 600 mg of clopidogrel: meta-analysis of individual patient data from 4 randomized clinical trials
Mehilli, J.
Berger, P. B.
Ndrepepa, G.
Kalyanasundaram, A.
Schulz, S.
Seyfarth, M.
Kastrati, A.
Schomig, A.
EUROPEAN HEART JOURNAL, 2007, 28 : 193 - 194
[39] Meta-Analysis of Randomized Controlled Trials and Adjusted Observational Results of Use of Clopidogrel, Aspirin, and Oral Anticoagulants in Patients Undergoing Percutaneous Coronary Intervention
D'Ascenzo, Fabrizio
Taha, Salma
Moretti, Claudio
Omede, Pierluigi
Grossomarra, Walter
Persson, Jonas
Lamberts, Morten
Dewilde, Willem
Rubboli, Andrea
Fernandez, Sergio
Cerrato, Enrico
Meynet, Ilaria
Ballocca, Flavia
Barbero, Umberto
Quadri, Giorgio
Giordana, Francesca
Conrotto, Federico
Capodanno, Davide
DiNicolantonio, James
Bangalore, Sripal
Reed, Matthew
Meier, Pascal
Zoccai, Giuseppe
Gaita, Fiorenzo
AMERICAN JOURNAL OF CARDIOLOGY, 2015, 115 (09): : 1185 - 1193
[40] Same Day Discharges in Patients Undergoing Elective Percutaneous Coronary Intervention to Chronic Total Occlusions: Experience From a Busy UK Cardiac Center
Sinha, Aish
Hanley, Cara
Shannon, Joanne
Achan, Vinod
Little, Callum
Chua, Tuan
Rathore, Sudhir
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (18) : B121 - B121

← 1 2 3 4 5 →